Author:
Byun Junho,Wu Yina,Park Jinwon,Kim Jung Suk,Li Qiaoyun,Choi Jaehyun,Shin Namjo,Lan Meng,Cai Yu,Lee Jaiwoo,Oh Yu-Kyoung
Publisher
Springer Science and Business Media LLC
Reference117 articles.
1. Barbier AJ, Jiang AY, Zhang P, Wooster R, Anderson DG. The clinical progress of mRNA vaccines and immunotherapies. Nat Biotechnol. 2022;40(6):840–54.
2. Esrick EB, Lehmann LE, Biffi A, Achebe M, Brendel C, Ciuculescu MF, et al. Post-transcriptional genetic silencing of BCL11A to treat sickle cell disease. N Engl J Med. 2021;384(3):205–15.
3. Wang C, Zhang Y, Dong Y. Lipid nanoparticle-mRNA formulations for therapeutic applications. Acc Chem Res. 2021;54(23):4283–93.
4. Sabnis S, Kumarasinghe ES, Salerno T, Mihai C, Ketova T, Senn JJ, et al. A novel amino lipid series for mRNA delivery: improved endosomal escape and sustained pharmacology and safety in non-human primates. Mol Ther. 2018;26(6):1509–19.
5. Frangoul H, Altshuler D, Cappellini D, Chen YS, Domm J, Eustace BK, et al. CRISPR-Cas9 gene editing for sickle cell disease and beta-thalassemia. N Engl J Med. 2021;384(23): e91.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent Advances in Drug Delivery;The AAPS Journal;2024-04-15
2. Chitosan nanocarriers for non-coding RNA therapeutics: A review;International Journal of Biological Macromolecules;2024-04
3. Nanomedicine-Based Cancer Immunotherapy;Interdisciplinary Cancer Research;2024